Explore more publications!

Suriname Tech News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Suriname Tech News.

Press releases published on November 17, 2025

Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder
World’s Leading Scientific Supercomputing Centers Adopt NVIDIA NVQLink to Integrate Grace Blackwell Platform With Quantum Processors
NVIDIA and RIKEN Advance Japan’s Scientific Frontiers With New Supercomputers for AI and Quantum Computing
SEON CEO Tamas Kadar to Present at Citi’s 14th Annual FinTech Conference
Constellation Software’s Harris Operating Group Completes Agreement to Acquire TECVIA Holding GmbH
GigaCloud Technology Inc Again Recognized in the Top 20 on Forbes’ List of America’s Most Successful Small-Cap Companies
Spirit Blockchain Capital Inc. Provides Corporate Update on Business Strategy and Clarifies Operating Model
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
CTW Announces Fiscal Year 2025 Financial Results
AIRE Launches Internal AI-Powered Engagement Assistant to Automate Lead Management and Streamline Mortgage Workflow
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
Crescent Biopharma Announces Grants of Inducement Awards
Microchip Technology to Present at the Wells Fargo 9th Annual TMT Summit
Click Holdings Limited (CLIK) Announces Strategic Acquisitions of HK-based HR Specialists to Ignite Synergies and Accelerate Market Leadership in Human Resources Solutions
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions